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Abstract
Nijmegen breakage syndrom e (N B S), a 
rare autosomal recessive condition also 
known as ataxia telangiectasia (AT) vari­
ants VI and V2, is characterised by m icro­
cephaly, typical facies, short stature, 
im m unodeficiency, and chrom osom al in ­
stability. We report the clinical, im m uno­
logical, chrom osom al, and cell biological 
findings in 42 patients who are included in  
the NBS Registry in Nijm egen. The im ­
munological, chrom osom al, and cell b io­
logical findings resem ble those in AT, but 
the clinical findings are quite different, 
NBS appears to be a separate entity not 
allelic with AT.
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Nijmegen breakage syndrome (NBS) is a rare 
autosomal recessive condition, characterised 
by microcephaly, typical face, short stature, 
chromosomal instability, and im m uno­
deficiency accompanied by recurrent infections 
and predisposition to malignancies (M IM  No 
251260). Since the recognition of the first two 
patients in 1981,1 we have included 42 patients 
in our NBS Registry in Nijmegen,1-11 The dis­
ease appears to be prevalent among the eastern 
and central European population, in particular 
among the Polish people.23 Although the im­
munological, cytogenetic, and cell biological 
findings in NBS resemble those in ataxia te­
langiectasia (AT), the clinical findings are quite 
different. NBS has been proposed as an allelic 
form of AT and designated as an AT variant 
with two complementation groups, VI and V2.
Recently the gene for AT on chromosone 
llq22-23 has been identified (ATM =  AT m ut­
ated) and found to be m utated in AT patients 
from all four complementation groups.12 At 
present there is little information on the pos­
sible chromosomal location of the NBS gene(s). 
The AT locus, however, has been excluded 
from harbouring die NBS gene.1113-15
Clinical description
GROWTH AND DEVELOPM ENT
The growth retardation in NBS patients can 
be ofpre- or postnatal onset. In 70% of patients, 
birth weight and birth length conform to gest­
ational age. The head circumference (OFC) at 
birth varies between 26‘5 cm and 36 cm; 75% 
of patients are born with an OFC below the 
3rd centile, This implies that not all patients 
are microcephalic at birth. However, they all 
develop progressive and severe microcephaly 
during the first months of life.3 Height falls 
below the 10th centile in all patients. From  the 
first stages of development onwards growth 
retardation is observed. After a few years a 
slight improvement is seen and height is on 
average almost on the 3rd centile. T he growth 
retardation is proportionate and weight cor­
responds to length. Bone age can be somewhat 
retarded.3 Little is known about the sexual 
maturation of patients with NBS. The only 
endocrinological abnorm ality  described as 
yet is ovarian dysgenesis in two pa tien ts4 
(K Chrzanowska, personal communication).
Developmental milestones are mostly not 
delayed during the first year of life. M ental 
development is normal in 35% of NBS patients, 
45% have borderline retardation, while 20% 
are moderately retarded.
None of the patients has signs of cerebellar 
ataxia, apraxic eye movements, or other neuro­
logical abnormalities, except for two girls de­
scribed by Curry et al37 who had clinical 
symptoms of both NBS and AT. Their con­
dition was considered to be an AT variant 
and referred to as “ATFresno”, representing 
a distinct entity.16 Complementation studies 
performed in 1988 assigned these twin sisters 
to NBS complementation group V I.7
CRANIOFACIAL FINDINGS
The craniofacial characteristics become more 
obvious with age.23 This is probably also be­
cause of the progressive and severe m i­
crocephaly in all patients. The hair becomes 
sparse in half of the NBS patients. The face is 
characterised by a receding forehead, prom ­
inent midface with a long nose and long phil- 
trum, receding m andible3 upward slanting 
palpebral fissures, large ears with dysplastic 
helices, and freckles on the cheeks and nose 
(figs 1 and 2). Subtle scleral telangiectasia can 
be present; this has been noted in 10 out of 25 
patients.37
SKIN
Pigmentation abnormalities are present in most 
patients. Freckles are mostly seen on the face.
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Figure 1 Patient from Weemaes et all (left) at 9 years of age and (centre and light) at 24 years of age. Note the 
microcephaly\ receding forehead> slightly upward slanting palpebral fissures^ freckles} and prominent midface.
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Two to five café au 1 ait-like spots are found in 
half of the patients and most also have some 
vitiligo spots. Cutaneous telangiectasia have 
been noted in only two patients.38 Sun sensi­
tivity of the eyelids can be present.23
10
CONGENITAL MALFORMATIONS
Congenital malformations reported once each 
are: preaxial polydactyly,3 occipitai cyst, 
hydrocephalus/ choanal atresia,2 cleft lip and 
palate,2 hypospadias/1 and a single ectopic kid­
ney.3 In three patients anal atresia was present 
at b i r th /5 and in another three patients hydro­
nephrosis has been diagnosed.26
INFECTIONS
Respiratory tract infections occur in almost 
all patients with NBS. Pneumonia, bronchitis, 
otitis media, sinusitis, and mastoiditis are fre­
quently seen. Complications such as bron­
chiectasis, respiratory insufficiency, and even
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Figure 2 Typical facial features in an 8 year old boy with micmcephalys long prominent 
nose* and small chin.
death from respiratory failure can ocur. In three 
patients no respiratory tract infections were 
reported, but two of them were only 8 and 18 
months old at the time of reporting.11 The 
other patient is a 4 year old girl who had no 
disturbance of her cellular immunity.8 Urinary 
tract infections repeatedly occur in 15% of 
patients with NBS. Gastrointestinal infections 
with diarrhoea have also been mentioned in 
15% of patients.
PREDISPOSITION TO MALIGNANCIES
Both immunodeficiency and chromosome in­
stability probably predispose to malignancies. 
In NBS patients there is a tendency to develop 
lymphomas at a young age. So far, 12 patients 
varying in age from 1 to 22 years have developed 
a lymphoma. One patient developed a glioma 
at the age of 12 years, one patient a me- 
dulloblastoma at 15 years, and one patient a 
rhabdomyosarcoma at 4 years. Two patients 
who developed a lymphoma are still alive, the 
others died within a few months to years after 
the malignancy had been diagnosed. When 
treating malignancies in these patients, cy­
tostatics should be the first choice. However, 
radiomimetics (for example, bleomycin) should 
be avoided, and the chemotherapy doses should 
be reduced.17 Radiation therapy should also be 
avoided, since x irradiation can induce malig­
nancies in NBS patients. If necessary, as can 
be the case in solid tumours, an estimation of 
the individual dose is recommended.18
NECROPSY FINDINGS
Of the 42 patients included in the NBS registry 
15 have died, four patients from bron­
chopneumonia, 10 from lymphoid malignancy, 
and one patient who developed a medullo- 
blastoma. An extensive necropsy was per­
formed on only one patient.19 In this patient 
important findings were the extremely reduced 
brain weight and the absence of diffuse cortical 
cerebellar degeneration, the presence of which 
is characteristic of AT. The thymus showed
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simple dysplasia. Limited necropsy data from 
other patients confirm thymus dysplasia or even 
thymus aplasia.2
Im m unological disturbances
The immune deficiency in NBS patients is 
relatively severe and concerns the humoral and 
cellular immune system. The humoral im­
munodeficiency is characterised by disturbed 
serum immunoglobulins; agammaglobulin- 
aemia, IgA deficiency, and IgG2 and IgG4 
deficiency can be found. In one patient im­
munological attrition was noticed. As well as 
IgA deficiency that he had had for years, he 
developed agammaglobulinaemia at 24 years 
of age, after he had been treated with cytostatics 
for a lymphoma.20 The defective cellular im­
munity is characterised by mild to moderate 
lymphopenia with decreased CD3 -f and 
CD4 +(helper) cells and a decreased CD4 +  : 
C D 8+ (suppressor) cell ratio. The in vitro 
response of lymphocytes to mitogens is im­
paired. The patient described by Barbi et a f  
was the only one reported to have normal T  
cell immunity and had no recurrent infections 
at the age of 4 years.8
Cytogenetic features
NBS patients basically have a normal karyo­
type. Cultured T  lymphocytes often show an 
extremely low mitotic index., in which case 
cytogenetic analysis can be very difficult. In all 
patients structural chromosome aberrations are 
present in 10 to 35% of metaphases of cultured 
T  cells. M ost of the rearrangements pref­
erentially occur in chromosomes 7 or 14 or 
both at bands 7pl3^ 7q35, 1 4 q ll ,  and 14q32, 
die same breakpoints as found in AT. These 
breakpoints coincide with the location of genes 
having immune function.21
Inv(7)(pl3q35) is the most frequently 
detected ab erration in N BS. Other re­
arrangements are t(7;14) (p l3 ;q l l ) ,  t(7;14) 
(q35 ;q ll)5t(7;7) (P 13;q35), andt(14;14) (q l l ;  
q32).
Inv(14)(qllq32) had not been found in 
NBS patients until recently when it was de­
tected in a lymphocyte culture of a 24 year 
old patient.20 In  fibroblasts, chromatid type 
instability has been observed.1 3 5 8 In one case 
chromosomal rearrangements were found in 
33% of fibroblasts, but without involvement 
of chromosomes 7 or 14.4 No chromosomal 
instability has been observed in bone marrow 
cells.1
Alphafetoprotein (AFP) levels
Serum AFP levels are normal in NBS patients, 
in contrast to AT patients, in whom an in­
creased serum AFP level is one of the hallmarks. 
The only patients with abnormally increased 
serum AFP levels are the twins with ATFresno, 
assigned to NBS complementation group V I .7 
In two patients, serum AFP levels were raised 
at the age of 5 months, but decreased to normal 
by 15 months and 2 years respectively.38
R adioresistant D NA  synthesis (RDS) and 
radiation hypersensitivity
Increased sensitivity of both lymphocytes and 
fibroblasts from NBS patients to ionising 
radiation or to radiomimetics, and radio­
resistance of D N A  replication, have been es­
tablished. So far, all patients tested have shown 
an abnormally increased rate of cell death and 
chromosome damage after x or gamma ir­
radiation. T he inhibition of D N A  synthesis 
after x or gamma irradiation is two to three 
times less pronounced than in normal cells.3622 
The results are indistinguishable from AT.
G enetics and m olecular studies
NBS is an autosomal recessive condition. It 
has been diagnosed in at least 42 patients, 23 
males and 19 females from 29 families. The 
NBS Registry contains 12 sibships among the 
42 patients included,
NBS seems to be more prevalent among the 
Polish people. Twenty-one of the 42 patients 
have been diagnosed by one of the authors 
(KHC) in Warsaw. T he aetiology of NBS is 
still completely unknown. Because the im­
munological, cytogenetic, and cell biological 
findings in NBS are almost the same as in AT, 
the elucidation of the AT gene would be an 
important step forwards for unravelling the 
genetic basis of NBS. Although NBS proved 
not to be allelic to AT, the gene responsible 
for NBS may be similar to the ATM  ( =  AT 
mutated) gene and have comparable functions. 
The ATM gene on chromosome 1 lq22-23 was 
found to be m utated in AT patients from all 
complementation groups. A partial ATM com­
plementary D N A  clone encoded a putative 
protein with sequence similarities suggesting 
involvement of the ATM  gene product in signal 
transduction, cellular responses to DNA dam- 
age3 and cell cycle control functions that are 
defective in AT.12
The observation of non-linkage of NBS 
with the ATM gene was corroborated by the 
study of K om atsu,23 who found non-com ­
plementation of NBS fibroblasts with chro­
mosome 11.
Hitherto, NBS patients have been divided 
into two different complementation groups, 
VI and V2, whereas AT patients have been 
represented in four other separate groups: A, 
C, D, and E .1622 T he characterisation of the 
ATM  gene and convergence of all com­
plementation groups into one gene requires 
reconsideration of the complementation groups 
in NBS. NBS is probably also a homogeneous 
disorder. Knowledge about the ATM gene 
products and their function could provide im­
portant clues for the aetiology of NBS.
Prenatal diagnosis
As the aetiology of NBS is still unknown, pos­
sible methods of prenatal diagnosis must de­
pend on the demonstration of the biochemical 
findings of the disease. The assessment of spon­
taneous or radiation induced chromosome ab­
errations in prenatal tissue has been reported 
in only a few AT cases.24 T he disadvantage of
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this method is that a large number of mitoses 
in chorionic villus (CV) or amniotic fluid (AF) 
cells have to be analysed. Radioresistant DNA 
synthesis (RDS) assay on cultured CV or AF 
cells has proven to be a reliable method for 
first trimester prenatal diagnosis of NBS and 
of AT. The prerequisite for reliable prenatal 
diagnosis with this method is the demonstration 
of increased RDS in fibroblasts of the index 
patient.25
Differential diagnosis
The well known chromosome instability dis­
orders are Fanconi anaemia, Bloom’s syn­
drome, and ataxia telangiectasia. Fanconi 
anaemia is characterised by short stature, pan­
cytopenia, radial hypoplasia, and brownish 
hyperpigmentation. Important hallmarks of 
Bloom’s syndrome are severe growth re­
tardation of prenatal onset, sunlight sensitivity 
leading to telangiectatic erythema, and specific 
chromosome instability with a high frequency 
of sister chromatid exchanges. Common find­
ings of both AT and NBS are immuno­
deficiency, chromosome instability with mul­
tiple chromosome 7 or 14 rearrangements, 
chromosomal hypersensitivity to x rays, and 
radioresistance of DNA replication. The 
classical clinical findings in AT are progressive 
cerebellar ataxia, oculocutaneous telangi­
ectasia, and raised serum AFP levels, which 
are absent in NBS.
Conclusion
Because patients with NBS have an increased 
risk of developing malignancies, it is important 
to diagnose this disease at an early age. In NBS 
patients x irradiation should be avoided as 
much as possible, for therapeutic but also for 
diagnostic reasons.
In all patients with unexplained early pro­
gressive microcephaly and growth retardation, 
chromosome instability analysis should be per­
formed, in order to establish or exclude a chro­
mosome instability disorder.
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